Study guide
1.2 NABP Competency Areas & Weights
Illinois MPJE Pharmacy Jurisprudence
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the Illinois MPJE 1.2 NABP Competency Areas & Weights 1.3 How to Use This Guide & Study Strategy
2 Chapter 2: Federal Controlled Substances Foundations
2.1 CSA Schedules I–V & Illinois Alignment 2.2 DEA Registration, Forms 222/106/41 & Security 2.3 Federal CS Prescription Rules (CII–CV) 2.4 Inventories, Recordkeeping & Theft/Loss
3 Chapter 3: Federal Drug Regulation, Privacy & Supply Chain
3.1 FD&C Act, Legend vs OTC, Misbranding & Adulteration 3.2 OBRA '90, Medicaid DUR & Federal Counseling Floor 3.3 HIPAA Privacy for Pharmacy 3.4 DSCSA & Drug Supply Chain Integrity
4 Chapter 4: IDFPR, Licensure & Eligibility
4.1 IDFPR Authority & Sources of Illinois Pharmacy Law 4.2 Pharmacist Licensure by Exam & Score Transfer 4.3 License Transfer (Reciprocity) & Background Checks 4.4 Interns, Preceptors & Experiential Requirements
5 Chapter 5: Renewal, CE, PIC & Discipline
5.1 License Renewal & 30-Hour Biennial CE 5.2 Pharmacist-in-Charge Duties 5.3 Discipline & Unprofessional Conduct 5.4 Impaired Practitioners & Mandatory Reporting
6 Chapter 6: Technicians, Interns & Supervision
6.1 Technician Registration, Training & Certification 6.2 Supervision, Scope & No Fixed Tech Ratio 6.3 Intern Scope, Delegation & Final Verification
7 Chapter 7: Prescription Authority & Validity
7.1 Who May Prescribe in Illinois 7.2 Prescription Content & Validity Requirements 7.3 Controlled Substance Prescribing (720 ILCS 570 + Federal) 7.4 Refills, Partial Fills & E-Prescribing Mandate
8 Chapter 8: Advanced IL Pharmacist Practice
8.1 Collaborative Practice Agreements & Clinical Services 8.2 Immunizations & Vaccine Administration 8.3 Naloxone Access & Opioid Antagonists 8.4 Drug Administration & Therapy Management
9 Chapter 9: Counseling, DUR & Patient Safety
9.1 Patient Counseling Requirements 9.2 Prospective Drug Utilization Review 9.3 Returning & Reusing Drugs
10 Chapter 10: ILPMP & Opioid Public-Health Laws
10.1 Illinois PMP Overview, Reporting & Access 10.2 Mandatory Queries, Designees & Documentation 10.3 Legitimate Medical Purpose & Red Flags
11 Chapter 11: Dispensing: Transfers, Labels & Substitution
11.1 Prescription Transfers Between Pharmacies 11.2 Labeling & Packaging of Dispensed Drugs 11.3 Generic Substitution & Product Selection 11.4 Emergency Dispensing, OTC/BTC & Pseudoephedrine
12 Chapter 12: Pharmacy Operations & Facilities
12.1 Pharmacy Permits, Classifications & Inspections 12.2 Security, Automated Systems & Self-Service Kiosks 12.3 Operational Recordkeeping & Inventories 12.4 Central Fill, Delivery & Remote Services
13 Chapter 13: Compounding & Hazardous Drugs
13.1 Sterile, Nonsterile & Hazardous Compounding 13.2 Illinois Compounding Rules & Beyond-Use Dates
14 Chapter 14: Test-Day Strategy & Final Review
14.1 When Illinois Law Is Stricter Than Federal Law 14.2 Test-Day Strategy & Common Traps
1.2 NABP Competency Areas & Weights
Key Takeaways Explain This Topic AI
The current NABP MPJE competency blueprint (in effect for exams through February 28, 2027) uses four areas: Licensure/Personnel 22%, Pharmacist Practice 33%, Dispensing 24%, and Operations 21%.
Area 2 Pharmacist Practice is the largest slice at 33%—allocate the most study time to prescribing authority, prescriptions, refills, counseling, therapy management, returns, and confidentiality.
NABP publishes competency statements, not a federal/state score split; items test integrated application of law to practice scenarios.
A new Content Outline takes effect March 1, 2027; this guide teaches the current four-area statements used for exams through February 2027.
Map Illinois sources onto the areas: 225 ILCS 85 and Part 1330 dominate personnel and operations; 720 ILCS 570 and ILPMP dominate CS prescribing and dispensing; federal CSA/DEA/FD&C/HIPAA/OBRA/DSCSA cut across all four.
Last updated: August 2026
1.2 NABP Competency Areas & Weights
Quick Answer: Until February 28, 2027 , the Illinois MPJE is built on four NABP competency areas : Licensure/Personnel 22% , Pharmacist Practice 33% , Dispensing Requirements 24% , and Pharmacy Operations 21% . There is no separate federal score and state score —items integrate both. A new Content Outline takes effect March 1, 2027 ; this guide teaches the current statements used for exams through February 2027.
Understanding the blueprint is how you stop studying “everything equally” and start investing hours where the exam invests items.
The Four Competency Areas (Current Statements)
Area Weight One-line focus
1. Licensure / Personnel 22% Who may practice, how people are licensed or registered, and how they are supervised or disciplined
2. Pharmacist Practice 33% How pharmacists exercise legal authority over prescriptions, therapy, counseling, and patient-facing duties
3. Dispensing Requirements 24% The legality of releasing a product—purpose, transfers, PMP, labels, packaging, OTC/BTC, hard stops
4. Pharmacy Operations 21% Systems of the pharmacy: records, storage, inventories, compounding, delivery, permits, inspections
Area 2 is the largest. If your calendar only has room for deep mastery of one slice first, make it practice law—then loop back to strengthen Areas 1, 3, and 4.
Area 1 — Licensure / Personnel (22%)
Expect items about who is allowed to do what , and what happens when credentials, CE, or conduct fail.
High-yield subtopics (NABP-style statements):
Pharmacist qualifications and scope — licensure by exam or transfer; what “practice of pharmacy” means under 225 ILCS 85
Pharmacist-in-charge (PIC) — named on the pharmacy license; operational responsibility for practice standards
Non-pharmacist personnel — technician registration and training; intern status; what techs cannot do (counsel, final clinical verification in ordinary workflows, independent professional judgment)
Exams, internships, renewals — eligibility paths; 30 hours of CE per 24-month renewal cycle concepts; first-renewal nuances when taught later
Disciplinary actions — unprofessional conduct, sanctions, what IDFPR can do to a license
Impaired-practice programs — recognition, reporting, and diversion of impaired practitioners into appropriate pathways
Illinois mapping: 225 ILCS 85 and 68 Ill. Adm. Code 1330 carry most personnel and board-power rules. Federal law rarely “licenses the technician,” but federal CS access and security rules still constrain who may handle controlled substances.
Exam trap: Illinois has no fixed pharmacist:technician numeric ratio —supervision turns on professional judgment and regulatory standards , not a single ratio slogan from another state. Memorizing a “2:1” or “3:1” from a different jurisdiction is a classic wrong answer.
Area 2 — Pharmacist Practice (33%)
This is the heaviest area. Treat it as the spine of your study plan.
High-yield subtopics:
Prescribing authority — who may issue prescriptions in Illinois (physicians, advanced practice providers within scope, dentists, etc.) and collaborative/protocol arrangements for pharmacists
Non-controlled prescriptions — required elements, validity, authenticity, and when to refuse
Controlled-substance prescriptions — federal CSA/DEA rules plus 720 ILCS 570 and Illinois e-prescribing mandates with limited exceptions
Refills and partial fills — schedule-specific limits; documentation; partial-fill rules that differ by schedule and circumstance
Administration and therapy management — immunizations, drug administration, collaborative practice / therapy management frameworks
- Counseling — Illinois counseling duties layered on the federal OBRA ’90 Medicaid floor
- Returning and reusing drugs — when returns are prohibited; safety and integrity constraints
- Public-health quality and safety — naloxone/opioid antagonist access, red-flag responses, quality expectations
- Confidentiality — HIPAA privacy + state expectations for protecting patient information
Illinois mapping: Area 2 is where federal floor + Illinois stricter duty collisions are most frequent. A federally acceptable answer can still be wrong if Illinois counseling, e-prescribing, collaborative practice, or CS rules demand more.
Area 3 — Dispensing Requirements (24%)
Dispensing is the release decision : may this product leave the pharmacy for this patient right now?
High-yield subtopics:
Legitimate medical purpose — corresponding responsibility for CS; recognizing red flags without abandoning patients unlawfully
Prescription transfers — transferability by schedule; documentation between pharmacies
Prescription monitoring (ILPMP) — dispenser reporting of Schedule II–V (except testosterone) plus designated drugs of interest, and access/designee rules for pharmacists. Keep the actors straight: the statutory mandatory query/documentation duty runs to prescribers (expanded to all C-II opioids, C-IV benzodiazepines, and initial C-II stimulants by PA 104-0512 , effective January 1, 2027 ), while the pharmacist uses ILPMP under corresponding responsibility and professional judgment (Section 10.2)
Exceptions to ordinary dispensing/refilling — emergency supplies, emergency oral CS procedures where allowed, documented exceptions
- Labeling — required label elements for dispensed products
- Packaging — child-resistant packaging floors, special packaging, integrity
- Conditions that prohibit dispensing — expired, recalled, incomplete Rx, suspected diversion, legal hard stops
OTC / BTC — behind-the-counter products (e.g., pseudoephedrine sales limits and logs) and pharmacist judgment at the counter
Illinois mapping: ILPMP ( ilpmp.org ) is a high-stakes Illinois overlay on federal CS rules, and the PA 104-0512 expansion effective January 1, 2027 means candidates must stay current with ILPMP guidance—not just DEA manuals. Section 10.2 separates the prescriber mandate from the dispenser duty in detail; conflating the two is one of the most common ILPMP misses.
Area 4 — Pharmacy Operations (21%)
Operations items test the system , not a single prescription vignette in isolation.
High-yield subtopics:
Ordering and distribution records — DEA Forms 222 (or electronic equivalent), invoices, CS paper trails
Storage and security — physical security, limited access, automated systems, self-service kiosks where Illinois allows them under rule
Hazardous drugs — handling and operational controls (often tied to USP and state adoption/enforcement concepts)
Non-pharmacist access — who may enter restricted areas; after-hours concepts
Controlled-substance inventories — initial and biennial (or otherwise required) inventories; theft/loss Form 106 ; destruction Form 41
- Delivery — mailing/delivery rules and chain-of-custody expectations
- Product selection — generic substitution and Illinois product-selection standards
- Compounding — sterile, nonsterile, and hazardous compounding controls; beyond-use dating concepts
- Central fill / remote models — responsibilities split between originating and filling pharmacies
Facility permits, inspections, and discipline — pharmacy classifications, inspections, sanctions against the site as well as the individual
Illinois mapping: Part 1330 and permit rules under 225 ILCS 85 dominate facility operations; federal DEA security and inventory rules still bind every CS stockroom.
How Federal vs. Illinois Law Maps Across Areas
Use this mental model when you tag a practice miss:
- Blueprint area Dominant Illinois sources Dominant federal sources
- Area 1 Personnel 225 ILCS 85 , Part 1330 , IDFPR CE/discipline Limited (often CS access/security)
Area 2 Practice 225 ILCS 85 , 720 ILCS 570 , Part 1330 , collaborative/immunization rules CSA/DEA Rx rules, OBRA ’90, HIPAA
Area 3 Dispensing ILPMP , 720 ILCS 570 , labeling/transfer rules in state law CSA corresponding responsibility, packaging floors
Area 4 Operations Permits, compounding, automation under 85 / 1330 DEA records/inventories/security, DSCSA, USP-related federal expectations
New Content Outline (March 1, 2027)
NABP will implement a new MPJE Content Outline effective March 1, 2027 . Candidates testing on or after that date must study the new outline from official NABP materials. This guide teaches the current four-area Competency Statements that govern exams through February 28, 2027 . If your test date straddles the changeover, verify the outline that applies to your appointment in NABP’s candidate bulletin before you freeze your study plan.
Study-Time Implications
For a candidate targeting ~120 content hours (adjust within the 90–160 range from exam logistics):
- Area Weight Approximate content hours
- Area 2 Practice 33% ~40 hours
- Area 3 Dispensing 24% ~29 hours
- Area 1 Licensure/Personnel 22% ~26 hours
- Area 4 Operations 21% ~25 hours
These hours are guides , not contracts. Shift time toward your weakest area after diagnostic practice, but do not starve Area 2—it is one-third of the exam.
How to Use the Blueprint While Reading Later Chapters
Every later chapter in this guide maps to one or more of these areas. When you finish a section, force three tags:
- Which NABP area? (1–4)
- Which source? (e.g., 720 ILCS 570, Part 1330, DEA Form 222, ILPMP)
- Stricter rule? (federal only / Illinois only / Illinois stricter)
That three-tag habit turns reading into exam performance.
Common Blueprint Mistakes
Weight blindness — perfect Form 222 recall but weak counseling, Rx validity, or ILPMP performance.
Federal-only mindset — choosing a DEA-correct option that violates a stricter Illinois duty.
Ratio slogans — importing another state’s technician ratio into Illinois items.
Ignoring personnel law — understudying PIC, CE, discipline, and tech scope because they “feel administrative.”
Outline date confusion — studying the March 2027 outline for a February 2027 test (or vice versa) without checking NABP.
Master these four areas and weights, then use the next section to turn the blueprint into a week-by-week study system .